ATE468533T1 - Enzym-protein-komplex - Google Patents

Enzym-protein-komplex

Info

Publication number
ATE468533T1
ATE468533T1 AT00127351T AT00127351T ATE468533T1 AT E468533 T1 ATE468533 T1 AT E468533T1 AT 00127351 T AT00127351 T AT 00127351T AT 00127351 T AT00127351 T AT 00127351T AT E468533 T1 ATE468533 T1 AT E468533T1
Authority
AT
Austria
Prior art keywords
enzyme
protein complex
protein
molecules
substance
Prior art date
Application number
AT00127351T
Other languages
English (en)
Inventor
Hirokazu Ohbayashi
Yuriko Kitano
Original Assignee
Nichirei Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18484551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE468533(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nichirei Biosciences Inc filed Critical Nichirei Biosciences Inc
Application granted granted Critical
Publication of ATE468533T1 publication Critical patent/ATE468533T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT00127351T 1999-12-22 2000-12-13 Enzym-protein-komplex ATE468533T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36555499A JP3781934B2 (ja) 1999-12-22 1999-12-22 酵素−タンパク質複合体

Publications (1)

Publication Number Publication Date
ATE468533T1 true ATE468533T1 (de) 2010-06-15

Family

ID=18484551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00127351T ATE468533T1 (de) 1999-12-22 2000-12-13 Enzym-protein-komplex

Country Status (16)

Country Link
US (2) US6613564B2 (de)
EP (1) EP1111385B2 (de)
JP (1) JP3781934B2 (de)
KR (2) KR100649378B1 (de)
CN (1) CN100338465C (de)
AT (1) ATE468533T1 (de)
AU (1) AU778084B2 (de)
CA (1) CA2328805C (de)
DE (1) DE60044420D1 (de)
DK (1) DK1111385T4 (de)
ES (1) ES2342146T5 (de)
IL (1) IL140413A0 (de)
NO (1) NO20006481L (de)
NZ (1) NZ508945A (de)
TW (1) TWI222516B (de)
ZA (1) ZA200007776B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003090780A1 (en) * 2002-04-26 2003-11-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Direct cell target analysis
JP3830501B2 (ja) 2003-01-17 2006-10-04 株式会社ティーティーシー アフィニティートラップリアクター、及びそれを用いたアンジオスタチン様断片のヒト血漿からの一段階精製プロセス
US7709047B2 (en) * 2003-01-24 2010-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
US7695752B2 (en) * 2003-01-24 2010-04-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target activated microtransfer
CA2592274C (en) * 2004-12-28 2014-09-09 Advanced Life Science Institute, Inc. Blocked enzyme-probe complex
WO2006116742A2 (en) * 2005-04-28 2006-11-02 Ventana Medical Systems, Inc. Fluorescent nanoparticles conjugated to antibodies via a peg linker
JP5628476B2 (ja) 2005-04-28 2014-11-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 抗体コンジュゲート
US7957466B2 (en) * 2005-09-16 2011-06-07 Sony Corporation Adaptive area of influence filter for moving object boundaries
ES2804129T3 (es) * 2005-11-23 2021-02-03 Ventana Med Syst Inc Conjugado anticuerpo-enzima
KR101814385B1 (ko) 2010-04-14 2018-01-04 에이껜 가가꾸 가부시끼가이샤 표식화 프로브-수용성 담체 복합체
EP3015474A4 (de) 2013-06-28 2017-01-11 Kyushu University, National University Corporation Proteinpolymerkomplex, t-gase-substrathaltiges polymer, t-gase-substrathaltiges monomer, verfahren zur herstellung des proteinpolymerkomplexes und verfahren zur verbesserung der proteinfunktion auf einer schnittstelle oder in der nähe einer schnittstelle eines fest-flüssig-materials
BR112016024624B1 (pt) 2014-04-23 2023-10-24 Nichirei Biosciences Inc. Produto de combinação para detectar marcador alvo, método para detectar um marcador alvo em uma amostra biológica obtida de um indivíduo e uso de um produto de combinação para detectar um marcador alvo em uma amostra biológica
RU2744836C2 (ru) 2014-05-08 2021-03-16 Новодиакс, Инк. Прямой иммуногистохимический анализ
CN106405087A (zh) * 2016-08-31 2017-02-15 上海科华生物工程股份有限公司 羊抗HBsAg多克隆抗体‑碱性磷酸酶交联物及其制备方法和检测试剂盒
EP4027141A4 (de) 2019-09-02 2023-09-27 Fujirebio Inc. Verfahren zur messung von lectin-assoziierter substanz, kit zur messung von lectin-assoziierter substanz und darin verwendetes blockiertes markiertes lectin
JP7361543B2 (ja) * 2019-09-02 2023-10-16 富士レビオ株式会社 Ａｆｐ－ｌ３測定方法及びａｆｐ－ｌ３測定キット、並びに、これらに用いるブロック化標識レクチン
US20230042563A1 (en) * 2019-12-25 2023-02-09 Fujirebio Inc. Immunochromatographic strip, immunochromatographic device, immunochromatographic kit, and method for detecting test substance
CN113358863A (zh) * 2021-06-10 2021-09-07 武汉原谷生物科技有限责任公司 一种多聚酶标记的制作方法
CN114397440A (zh) * 2022-01-20 2022-04-26 百盛(广州)生物制品有限公司 一种基于多聚赖氨酸大分子（dgl）结构的酶标二抗制备及其方法
WO2025037528A1 (ja) * 2023-08-15 2025-02-20 ソニーグループ株式会社 化合物、結合体、発光検出システムおよび測定装置

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122028A1 (de) * 1983-03-07 1984-10-17 E-Y Laboratories, Inc. Kolorimetrische Bestimmung von Enzymen, dafür geeignetes diagnostisches Gerät und ein Verfahren zur Herstellung dieses Geräts
DK188184A (da) * 1983-04-20 1984-10-21 Enzo Biochem Inc Fremgangsmaade til dannelse af et kompleks af biologisk aktive eller funktionelle forbindelser og anvendelse af forbindelserne
AU3844485A (en) * 1984-02-09 1985-08-15 Enzo Biochem Inc. Heterologous detection of cabeled dna
EP0155224A3 (de) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Chromogen-reagierende Funktion tragender Festphasenkomplex zum Nachweis eines Antikörpers, eines Antigens, eines Rezeptors oder eines Haptens
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US4699784A (en) 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
US5084560A (en) 1986-06-30 1992-01-28 Oncogen Immunoconjugates and methods for their use in tumor therapy
US4959306A (en) * 1986-11-28 1990-09-25 Sclavo, Inc. Labeling design for a binding assay reagent
GB8628488D0 (en) * 1986-11-28 1987-01-07 Baise Roile Ltd Edible product
CA1319593C (en) * 1987-03-03 1993-06-29 Kenji Chichibu Method of assaying high molecular hyaluronic acid and kit of reagents for such assay
US5028524A (en) * 1987-04-24 1991-07-02 Takeda Chemical Industries, Ltd. Assay for anti-pre-S antibody
JPS6423300A (en) * 1987-07-17 1989-01-25 Ricoh Kk Spectrum generation system
US5053520A (en) 1988-09-22 1991-10-01 Abbott Laboratories Heterobifunctional maleimido containing coupling agents
JPH03158758A (ja) 1989-11-17 1991-07-08 Tosoh Corp デキストランを介して結合した二以上の物質の複合体及び該複合体の製造方法
DK0594772T3 (de) 1991-07-04 1997-02-24 Immunodex K S
JP3158758B2 (ja) 1993-02-19 2001-04-23 松下電器産業株式会社 端末アダプタ装置とデータ伝送方法
EP0702793B1 (de) 1993-06-11 2003-08-27 Coulter International Corporation Anti-cd3-antikörper-aminodextran-konjugate zur induktion der t-zellen-aktivierung und vermehrung
JP3825815B2 (ja) 1994-01-31 2006-09-27 信義 清水 上皮細胞増殖因子レセプターに対するモノクローナル抗体の結合体ならびにその複合体およびその細胞への嵌入方法
CA2184282A1 (en) 1994-03-07 1995-09-14 Olavi Siiman Covalent immobilized antibodies on polymeric beads
DE69638321D1 (de) * 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
US5833924A (en) * 1995-12-22 1998-11-10 Universal Healthwatch, Inc. Sampling-assay device and interface system
JPH1084959A (ja) 1996-09-06 1998-04-07 Nobuyoshi Shimizu 細胞表面レセプターに対するモノクローナル抗体ならびにそのフラグメントの結合体ならびに複合体、それらの製法ならびに細胞への嵌入方法および使用方法
US5763158A (en) * 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
JP3524401B2 (ja) * 1998-09-16 2004-05-10 株式会社ニチレイ 酵素抗体複合体およびその製造方法

Also Published As

Publication number Publication date
CN1300942A (zh) 2001-06-27
AU7218400A (en) 2001-06-28
EP1111385B1 (de) 2010-05-19
CA2328805C (en) 2009-08-18
US6613564B2 (en) 2003-09-02
AU778084B2 (en) 2004-11-18
JP3781934B2 (ja) 2006-06-07
TWI222516B (en) 2004-10-21
US20040002146A1 (en) 2004-01-01
HK1037728A1 (zh) 2002-02-15
US7235369B2 (en) 2007-06-26
CA2328805A1 (en) 2001-06-22
EP1111385B2 (de) 2014-02-26
ZA200007776B (en) 2001-07-16
DK1111385T4 (da) 2014-06-02
ES2342146T5 (es) 2014-05-27
KR100649378B1 (ko) 2006-11-24
KR20010067472A (ko) 2001-07-12
JP2001181299A (ja) 2001-07-03
NO20006481D0 (no) 2000-12-19
NZ508945A (en) 2002-07-26
NO20006481L (no) 2001-06-25
CN100338465C (zh) 2007-09-19
KR100709052B1 (ko) 2007-04-18
US20010005583A1 (en) 2001-06-28
DE60044420D1 (de) 2010-07-01
ES2342146T3 (es) 2010-07-02
KR20060088864A (ko) 2006-08-07
DK1111385T3 (da) 2010-08-30
EP1111385A2 (de) 2001-06-27
EP1111385A3 (de) 2002-09-04
IL140413A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
ATE468533T1 (de) Enzym-protein-komplex
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
ATE353864T1 (de) Fluorierung von proteinen und peptiden für positronemissionstomographie
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
DE69714654D1 (de) Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen
WO2002042427A3 (en) Mass tags for quantitative analysis
WO2004041865A3 (en) Stabilized single domain antibodies
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
ATE237137T1 (de) Rückgewinnung und verwendungen von spezifischen bindungsreagenzen
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
DK0487301T3 (da) Fremgangsmåde til stabilisering af enzymkonjugater
ATE426158T1 (de) Mikrofluidisches extraktionsverfahren
WO2003106649A3 (en) CONJUGATE TEST AND USES THEREOF
PE20010046A1 (es) Anticuerpos anti-idiotipicos recombinantes
WO2002048403A3 (en) Multiplexed protein expression and activity assay
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
WO2003016904A3 (en) Peptide sequence tags and method of using same
DE3851221D1 (de) Nichttrennender festphasen-enzymtest.
ATE133422T1 (de) Peptide und deren benutzung
AU2001292118A1 (en) Dye-labelled peptide and its diagnostic use
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
WO2001000799A8 (fr) Nouvelle proteine et son adn
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
KR900007440A (ko) Reg 단백질을 인식하는 단일클론 항체
ATE200678T1 (de) Urogenitalkarzinom tlp peptidkomplex und abgeleitete antikörper

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties